Inhibition of VSMCs migration, proliferation and calcification, and facilitation of apoptosis with DPP-IV inhibitors could prove a novel method in modulating vascular disease in patients with type 2 diabetes. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.